Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Fate Therapeutics (NQ: FATE ) 2.430 +0.060 (+2.53%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Fate Therapeutics < Previous 1 2 3 4 5 6 7 8 9 Next > Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2022 Financial Results October 24, 2022 From Fate Therapeutics, Inc. Via GlobeNewswire Fate Therapeutics to Present Clinical and Preclinical Data for iPSC Product Platform at the Society for Immunotherapy of Cancer 37th Annual Meeting October 05, 2022 From Fate Therapeutics, Inc. Via GlobeNewswire Tesla, Meta, NVIDIA And Other Big Losers From Tuesday September 14, 2022 U.S. stocks closed sharply lower with the Nasdaq Composite dipping more than 5% on Tuesday. Here is the list of some big stocks moving lower in the previous session. Via Benzinga Fate Therapeutics Initiated With Hold Rating - Read Why July 28, 2022 Via Benzinga Despite Durability Questions, BMO Upgraded This Natural-Killer Cell Therapy Oncology Stock July 12, 2022 Via Benzinga Apple, Amazon, HP And Other Big Losers From Friday August 29, 2022 U.S. stocks closed sharply lower with the Dow Jones tumbling more than 1,000 points on Friday. Here is the list of some big stocks moving lower in the previous session. Via Benzinga Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday August 29, 2022 Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion. Via Benzinga This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving Premarket August 18, 2022 Gainers Via Benzinga 7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher August 17, 2022 These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up. Via InvestorPlace The 5 Top Stocks Cathie Wood Is Buying Now August 15, 2022 Cathie Wood's ETFs have performed well following the release of July's CPI report. Recent Cathie Wood stocks include NVTA, TDOC and RBLX. Via InvestorPlace Expert Ratings for Fate Therapeutics July 11, 2022 Within the last quarter, Fate Therapeutics (NASDAQ:FATE) has observed the following analyst ratings: Via Benzinga Recap: Fate Therapeutics Q1 Earnings May 04, 2022 Fate Therapeutics (NASDAQ:FATE) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga Earnings Scheduled For February 28, 2022 February 28, 2022 Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... Via Benzinga This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday August 17, 2022 Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids. Via Benzinga Cathie Wood Is Buying Up Red-Hot Fate Therapeutics (FATE) Stock August 12, 2022 FATE stock is in focus after Cathie Wood's Ark Invest purchased over 600,000 shares yesterday. This was Ark's first purchase since February. Via InvestorPlace Cathie Wood Scoops Up Over $20M Worth Of Fate Therapeutics Shares, Dumps More Twitter Stock August 12, 2022 Cathie Wood-led Ark Investment Management has bought 628,060 shares of clinical-stage biopharmaceutical company Fate Therapeutics Inc. (NASDAQ: FATE) through two of the firm’s exchange-traded funds... Via Benzinga 7 Small-Cap Stocks to Buy Before the Bull Market Returns August 07, 2022 These small-cap stocks to buy before the bull market returns have underperformed the market, but have immense potential for future gains. Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session August 04, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial August 03, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022 July 28, 2022 Via Benzinga 7 Cathie Wood Stocks Trading at a Discount Right Now July 26, 2022 These 7 Cathie Wood stocks are the best choices to buy in June. COIN, FATE, NTLA, MELI, TDOC, TSLA, and ZM can make excellent investments. Via InvestorPlace Beyond Meat, Canoo, Veru And More: 12 Short Squeeze Candidates To Watch July 20, 2022 One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky has just released a... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022 July 12, 2022 Upgrades Via Benzinga 7 Small-Cap Stocks to Buy in July 2022 July 04, 2022 These are the best small-cap stocks to buy for July 2022. ARCH, AVUV, CEIX, COUR, DVAX, FATE, and TENB can make great investments. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022 July 11, 2022 Upgrades Via Benzinga Will Another Enlivex Innovation Break The Glass Ceiling For Solid Tumor Treatments? June 14, 2022 Cell therapy — the use of stem cells and various engineered immune cells to target difficult-to-treat diseases like cancer and autoimmune conditions — has arguably been one of the big breakthroughs in... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022 June 03, 2022 Via Benzinga The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints May 04, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga What 4 Analyst Ratings Have To Say About Fate Therapeutics March 04, 2022 Within the last quarter, Fate Therapeutics (NASDAQ:FATE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... Via Benzinga Fate Therapeutics: Q4 Earnings Insights February 28, 2022 Fate Therapeutics (NASDAQ:FATE) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
